| Haviland Hearing Aids Inc. | |
|
1336 E Wisconsin Ave, Appleton, WI 54911-3969 | |
| (920) 733-7525 | |
| Not Available |
| Full Name | Haviland Hearing Aids Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 1336 E Wisconsin Ave, Appleton, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003947748 | NPI | - | NPPES |
| 42857800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 359 156 (Wisconsin) | Primary |
| Provider Name | Peter Zellmer |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1023153251 PECOS PAC ID: 1850494675 Enrollment ID: I20070316000162 |
News Archive
Aetna leaders will present the findings of a new study today at the Academy for Health Equity Conference in Littleton, Colorado. The study looked at the differences in the use of the emergency room (ER) by minority populations suffering from asthma and the potential to improve health outcomes and cost savings by addressing disparities in asthma ER visits.
Transgender individuals may experience significant improvement in psychological functioning after as little as 3-6 months of hormone therapy, with improved quality of life reported within 12 months of initiating therapy by both female-to-male and male-to-female transgender individuals, according to an article published in Transgender Health, a new peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).
› Verified 3 days ago
| Provider Name | Kyle Jordan Martell |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1770972697 PECOS PAC ID: 8426378399 Enrollment ID: I20150515000743 |
News Archive
Aetna leaders will present the findings of a new study today at the Academy for Health Equity Conference in Littleton, Colorado. The study looked at the differences in the use of the emergency room (ER) by minority populations suffering from asthma and the potential to improve health outcomes and cost savings by addressing disparities in asthma ER visits.
Transgender individuals may experience significant improvement in psychological functioning after as little as 3-6 months of hormone therapy, with improved quality of life reported within 12 months of initiating therapy by both female-to-male and male-to-female transgender individuals, according to an article published in Transgender Health, a new peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Haviland Hearing Aids Inc. 1336 E Wisconsin Ave, Appleton, WI 54911-3969 Ph: (920) 733-7525 | Haviland Hearing Aids Inc. 1336 E Wisconsin Ave, Appleton, WI 54911-3969 Ph: (920) 733-7525 |
News Archive
Aetna leaders will present the findings of a new study today at the Academy for Health Equity Conference in Littleton, Colorado. The study looked at the differences in the use of the emergency room (ER) by minority populations suffering from asthma and the potential to improve health outcomes and cost savings by addressing disparities in asthma ER visits.
Transgender individuals may experience significant improvement in psychological functioning after as little as 3-6 months of hormone therapy, with improved quality of life reported within 12 months of initiating therapy by both female-to-male and male-to-female transgender individuals, according to an article published in Transgender Health, a new peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).
› Verified 3 days ago
Mr. Peter John Zellmer, M.S., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 1336 E Wisconsin Ave, Appleton, WI 54911 Phone: 920-733-7525 Fax: 920-730-9403 | |
Audiology And Hearing Services Of The Fox Cities Audiologist Medicare: Medicare Enrolled Practice Location: 2245 S Oneida St, Appleton, WI 54915 Phone: 920-731-9611 Fax: 920-731-1950 | |
Brittany Uitenbroek, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: W3124 Van Roy Rd, Appleton, WI 54915 Phone: 920-915-9077 | |
Amy J Rietz, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1501 S Madison St, Appleton, WI 54915 Phone: 920-730-4443 | |
Dr. Stephanie Roberts Long, AUD DOCTOR AUDILOGY Audiologist Medicare: Accepting Medicare Assignments Practice Location: W3124 Van Roy Rd, Appleton, WI 54915 Phone: 920-915-9077 | |
Jacqueline Nicole Maxam, Audiologist Medicare: Medicare Enrolled Practice Location: 1520 N Meade St, Appleton, WI 54911 Phone: 920-734-7181 Fax: 920-734-0621 |